Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control

Journal of Clinical Oncology

Volumn 19, Issue 2, 2001, Pages 480-487

  Packer, R J ^a   Boyett, J M ^a   Janss, A J ^a   Stavrou, T ^a   Kun, L ^a   Wisoff, J ^a   Russo, C ^a   Geyer, R ^a   Phillips, P ^a   Kieran, M ^a   Greenberg, M ^a   Goldman, S ^a   Hyder, D ^a   Heideman, R ^a   Jones Wallace, D ^a   August, G P ^a   Smith, S H ^a   Moshang, T ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NORTH AMERICA; PRIORITY JOURNAL;

EID: 0035863507     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.2.480     Document Type: Article

References (22)

1. Medulloblastoma: Clinical and biologic aspects
2. Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group study
3. Long-term sequelae of cancer treatment on the central nervous system in childhood
4. Long-term endocrine sequelae after treatment of medulloblastoma: Prospective study of growth and thyroid function
5. Effect of spinal irradiation on growth
6. Evaluation of survival data and two new rank order statistics arising in its consideration
7. Regression models and life tables (with discussion)
8. Analysis of survival by tumor response
9. Growth hormone deficiency after treatment of acute leukemia in children
10. The effect of varying doses of cerebral irradiation on growth hormone production in childhood
11. Differential effects of cranial radiation on growth hormone response to arginine and insulin infusion
12. Brain tumor recurrence in children treated with growth hormone: The National Cooperative Growth Study experience
13. Does growth hormone increase the risk of malignancies?
14. Leukemia occurrence among growth hormone users
15. Leukemia in patients treated with growth hormone
16. Risk of leukemia after treatment with pituitary growth hormone
17. Rate of relapse of craniopharyngioma in children treated with growth hormone
18. Production of insulin-like growth factor-binding proteins by human central nervous system tumors
19. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo
20. Growth hormone receptor expression and function in meningiomas: Effect of a specific receptor antagonist
21. Growth hormone therapy in adults and children